5409372025-04-012025-06-305409372025-04-012025-06-30in-capmkt:OtherExpenses1Member5409372025-04-012025-06-30

AuditorDomain1

iso4217:INRxbrli:pureiso4217:INRxbrli:shares

540937

MEDICO

NOTLISTED

INE630Y01024

MEDICO REMEDIES LIMITED

Main Board

Equity

2025-04-01

2026-03-31

2025-08-08

2025-08-01

INR

Lakhs

Quarterly

First quarter

Single segment

manufacturer and exporter of pharmaceutical formulations

2025-08-08

15:00:00

2025-08-08

16:30:00

Declaration of unmodified opinion

false

The Company has not made any default on loans and debt securities and hence, the said disclosure is not applicable to the Company.

2025-04-01

2025-06-30

Unaudited

Standalone

382515000

6581000

389096000

287091000

6246000

-19951000

17036000

2811000

7690000

63833000

364756000

24340000

5358000

801000

6159000

18181000

12000

18193000

165968000

0.22

0.1592

1. The above unaudited standalone financial results of the company were reviewed and recommended by the audit committee on August 08, 2025 and subsequently approved by the Board of Directors at its meeting held on August 08, 2025. The review report has been filed with stock exchange and is available on the Company’s website. 2. The figures for the quarter ended on 31st March 2025 are balancing figures between the audited figures for the year ended 31st March 2025 and reviewed year to date figures upto nine month ended 31st December 2024. 3. The standalone financial results for the quarter ended on 30th June, 2025 have been subjected to Limited Review by statutory auditors of the company and the statutory auditors have issued unmodified report on unaudited financial results. 4. The above financial results have been prepared as per IND AS and all standards and requirements of IND AS are complied with by the company. 5. Medico Remedies Limited is a pharmaceutical formulation manufacturing company and the management reviews the performance of the company as a single operating segment in accordance with IND-AS 108 “Operating Segments” notified pursuant to Companies (Accounting Standard) Rules, 2015. Accordingly, no segment information/segment reporting has been furnished within. Details of geographical segments are disclosed below: PARTICULARS QE 30.06.2025 QE 31.03.2025 Amount (Rs. In Lakh) Amount (Rs. In Lakh) 1) Sales of products within India 539.65 628.52 2) Sales of products Outside India 3245.01 3457.77 Sub- Total 3784.66 4086.29 6.Previous periods figures have been regrouped / reclassified where required to make them compatible with the figures of current periods. 7.The company does not have any subsidiary/associate/joint venture company as on 30th June 2025. 8.The result for the quarter ended June 30, 2025 is available on the BSE Limited website (URL: www.bseindia.com), NSE Limited website (URL: www.nseindia.com) and on the Company’s website (URL: www.medicoremedies.com)

Other Expenses

63833000

-12000

12000

Unaudited

true

V J SHAH & CO

true

2028-06-30